SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-15-000791
Filing Date
2015-12-18
Accepted
2015-12-18 14:38:18
Documents
1
Period of Report
2015-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2970
  Complete submission text file 0000904454-15-000791.txt   4339
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address
Shah Nimesh (Reporting) CIK: 0001660394 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36075 | Film No.: 151296473